Clinical and immunologic assessment of sepsis and the systemic inflammatory response syndrome in cats

Journal of the American Veterinary Medical Association

Volumn 238, Issue 7, 2011, Pages 890-897

  DeClue, Amy E ^a   Delgado, Cherlene ^a   Chang, Chee hoon ^a   Sharp, Claire R ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CAT; CAT DISEASE; IMMUNOLOGY; MORTALITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CASE-CONTROL STUDIES; CAT DISEASES; CATS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALIA;

EID: 79953709717     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.238.7.890     Document Type: Article

References (37)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
2. A. Sepsis and the systemic inflammatory response syndrome In: Ettinger S, Feldman E, eds. Textbook of veterinary internal medicine. 7th ed. St Louis: Saunders Elsevier, 2010;523-528.
3. Sergeeff J, Armstrong PJ, Bunch SE. Hepatic abscesses in cats: 14 cases (1985-2002). J Vet Intern Med 2004;18:295-300.
4. Costello M, Drobatz K, Aronson L. Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis: 51 cases (1990-2001). J Am Vet Med Assoc 2004;225:897-902.
5. Brady CA, Otto CM, Winkle TJ, et al. Severe sepsis in cats: 29 cases (1986-1998). J Am Vet Med Assoc 2000;217:531-535.
6. Waddell L, Brady C, Drobatz K. Risk factors, prognostic indicators, and outcome of pyothorax in cats: 80 cases (1986-1999). J Am Vet Med Assoc 2002;221:819-824.
7. Barrs V, Allan G, Beatty J, et al. Feline pyothorax: a retrospective study of 27 cases in Australia. J Feline Med Surg 2005;7:211-222.
8. Calandra T, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990;161:982-987.
9. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-613.
10. Gogos CA, Drosou E, Bassaris HP, et al. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-180.
11. Martin C, Boisson C, Haccoun M, et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-1819.
12. Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 2007;36:253-260.
13. Otto C, Drobatz K, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65-70.
14. DeClue AE, Williams KJ, Sharp C, et al. Systemic response to low-dose endotoxin infusion in cats. Vet Immunol Immunopathol 2009;132:167-174.
15. Sharp CR, DeClue AE, Haak CE, et al. Evaluation of the antiendotoxin effects of polymyxin B in a feline model of endotoxemia. J Feline Med Surg 2010;12:278-285.
16. DeClue AE, Sharp CR, Cohen RL, et al. Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats. J Feline Med Surg 2010;12:754-759.
17. Mueller M, Ludwig L, Barton L. Use of closed-suction drains to treat generalized peritonitis in dogs and cats: 40 cases (1997-1999). J Am Vet Med Assoc 2001;219:789-794.
18. Walker A, Jang S, Hirsh D. Bacteria associated with pyothorax of dogs and cats: 98 cases (1989-1998). J Am Vet Med Assoc 2000;216:359-363.
19. DeClue AE, Cohn LA, Lechner E, et al. Subanesthetic doses of ketamine blunt endotoxin-induced plasma TNF-a activity in dogs. Am J Vet Res 2008;69:228-232.
20. Eberhardt JM, DeClue AE, Reinero CR. Chronic use of the immunomodulating tripeptide feG-COOH in experimental feline asthma. Vet Immunol Immunopathol 2009;132:175-180.
21. Kato H, Ohashi T, Matsushiro H, et al. Molecular cloning and functional expression of equine interleukin-1 receptor antagonist. Vet Immunol Immunopathol 1997;56:221-231.
22. Stich AN, DeClue AE. Pathogen associated molecular patterninduced TNF, IL-1beta, IL-6 and CXCL-8 production from feline whole blood culture. Res Vet Sci 2011;90:59-63.
23. Gosain A, Gamelli RL. A primer in cytokines. J Burn Care Rehabil 2005;26:7-12.
24. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778.
25. Oberhoffer M, Vogelsang H, Russwurm S, et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999;37:363-368.
26. Matsuda N, Hattori Y. Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J Pharmacol Sci 2006;101:189-198.
27. Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523-535.
28. Dinarello CA. Interleukin-1beta. Crit Care Med 2005;33:S460-462.
29. Song M, Kellum JA. Interleukin-6. Crit Care Med 2005;33:S463-465.
30. Friedland JS, Suputtamongkol Y, Remick DG, et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60:2402-2408.
31. Hack CE, Hart M, van Schijndel RJ, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60:2835-2842.
32. Marty C, Misset B, Tamion F, et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-679.
33. Patel RT, Deen KI, Youngs D, et al. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994;81:1306-1308.
34. de Morais H, Boiondo A. Disorders of chloride: hyperchloremia and hypochloremia. In: Dibartola S, ed. Fluid, electrolyte and acid-base disorders in small animal practice. 3rd ed. St Louis: Saunders Elsevier, 2006;80-91.
35. Okano S, Yoshida M, Fukushima U, et al. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet Rec 2002;150:245-246.
36. Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003;168:77-84.
37. Shapiro N, Howell MD, Bates DW, et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006;48:583-590.